 |
| Click to view YouTube explanation of palbociclib |
CANCER DIGEST – Feb. 23, 2015 –Women diagnosed with advanced breast cancer that has spread to other parts of the body achieved longer progression-free survival after treatment with a new oral drug, called palbociclib.
The new drug was recently approved by the FDA for metastatic breast cancer patients just beginning to undergo hormone therapy after an initial phase I clinical trial conducted by researchers in the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania.
